Annual Drug Patent Expirations for CLEVIPREX Cleviprex is a drug marketed by Chiesi and is included in one NDA. It is available from two suppliers. There are three patents protecting…
The post New patent expiration for Chiesi drug CLEVIPREX appeared fi…
Annual Drug Patent Expirations for XYREM Xyrem is a drug marketed by Jazz Pharms and is included in one NDA. It is available from one supplier. There are fourteen patents…
The post New patent expiration for Jazz Pharms drug XYREM appeared first on Drug…
New patent expiration for Jazz Pharms drug XYREM Read Post »
CLEVIPREX (clevidipine) Chiesi Patent: 5,856,346 Expiration: Jan 5, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post Drug Pat…
Drug Patent Expirations for the Week of January 3, 2021 Read Post »
CLEVIPREX (clevidipine) Chiesi Patent: 5,856,346 Expiration: Jan 5, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post Drug Pat…
Drug Patent Expirations for the Week of January 3, 2021 Read Post »
Annual Drug Patent Expirations for XYREM Xyrem is a drug marketed by Jazz Pharms and is included in one NDA. It is available from one supplier. There are fourteen patents…
The post New patent expiration for Jazz Pharms drug XYREM appeared first on Drug…
New patent expiration for Jazz Pharms drug XYREM Read Post »
SPRYCEL (dasatinib) Bristol myers squibb Patent: 6,596,746 Expiration: Dec 28, 2020 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]…
The post Drug P…
Drug Patent Expirations for the Week of December 27, 2020 Read Post »
Annual Drug Patent Expirations for SPRYCEL Sprycel is a drug marketed by Bristol Myers Squibb and is included in one NDA. It is available from one supplier. There are five…
The post New patent expiration for Bristol Myers drug SPRYCEL appeared first on…
New patent expiration for Bristol Myers drug SPRYCEL Read Post »
Annual Drug Patent Expirations for ALLEGRA-D+24+HOUR+ALLERGY+AND+CONGESTION Allegra-d 24 Hour Allergy And Congestion is a drug marketed by Sanofi Aventis Us and is included in one NDA. It is available from…
The post New patent expiration for Sanofi Ave…
New patent expiration for Sanofi Aventis drug ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION Read Post »
ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION (fexofenadine hydrochloride; pseudoephedrine hydrochloride) Sanofi aventis us Patent: 6,613,357 Expiration: Dec 25, 2020 See More … For more information on how DrugPatentWatch can help…
The post Drug Patent Expi…
Drug Patent Expirations for the Week of December 20, 2020 Read Post »
Annual Drug Patent Expirations for CLARINEX-D+12+HOUR Clarinex-d 12 Hour is a drug marketed by Merck Sharp Dohme and is included in one NDA. It is available from one supplier. There…
The post New patent expiration for Merck Sharp drug CLARINEX-D 12 HOU…
New patent expiration for Merck Sharp drug CLARINEX-D 12 HOUR Read Post »